Principles of pharmacogenetics and pharmacogenomics / 
edited by Russ B. Altman, David Flockhart, David B. Goldstein. 
 - Cambridge ;  New York :  Cambridge University Press,  2012. 
 - xii, 269 p. :  ill. (some col.), maps (some col.) ;  27 cm. 
<br/><br/>Includes bibliographical references 
<br/><br/>Part 1. Critical Concepts: Introduction to population diversity and genetic testing -- Genotyping technologies - - Pharmacokinetics: absorption, distribution, metabolism, excretion -- Overview: adverse drug reactions -- PharmGKB,a centralized resource for pharmacogenomic knowledge and discovery -- DrugBank -- Ethical considerations for pharmacogenomics: privacy and confidentiality -- Informedconsent in pharmacogenomic research and treatment -- Legal trends driving the clinical translation of pharmacogenomics -- Part 2. Therapeutic Areas: Oncologic drugs -- Pharmacogenetics and pharmacogenomics -- Statin-induced muscle toxicity -- Genomics of the drug-induced long-QT syndrome -- Pharmacogenetics of diabetes -- Pharmacogenetics - therapeutic area - respiratory -- Pharmacogenomics associated with therapy for acid-related disorders -- Pharmacogenetics of rheumatology: focus on rheumatoid arthritis -- Pharmacogenetics of obstetric therapeutics -- Pharmacogenomics of psychiatric drugs -- Pain and anesthesia -- HIV and antiretroviral therapy -- Application of pharmacogenetics and pharmacogenomics in pediatrics: what makes children different? -- Fetal and neonatal pharmacogenomics 
<br/><br/><label>ISBN: </label>9780521885379 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Pharmacogenetics.<br/>Pharmacological Phenomena--genetics.